These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34037734)

  • 1. Measuring the Burden of Opioid-Related Mortality in Ontario, Canada, During the COVID-19 Pandemic.
    Gomes T; Kitchen SA; Murray R
    JAMA Netw Open; 2021 May; 4(5):e2112865. PubMed ID: 34037734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Opioid Toxicity Deaths Among Adolescents and Young Adults in Ontario Prior To and During the COVID-19 Pandemic.
    Akbar S; Iacono A; Yang J; Antoniou T; Juurlink D; Sheikh H; Kurdyak P; Wu F; Cheng C; Leece P; Kolla G; Emblem J; Shearer D; Gomes T
    J Adolesc Health; 2024 Jul; 75(1):35-42. PubMed ID: 38597841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents and opioid-related outcomes amidst the COVID-19 pandemic.
    Romero RA; Young SD
    J Addict Dis; 2022; 40(1):126-130. PubMed ID: 33955321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in mortality for the general population and individuals with pre-pandemic acute care for alcohol or opioids during the COVID-19 pandemic in Ontario, Canada.
    Myran DT; Friesen EL; Pugliese M; Milani C; Tanuseputro P
    Can J Psychiatry; 2023 Nov; 68(11):876-879. PubMed ID: 36786153
    [No Abstract]   [Full Text] [Related]  

  • 5. Pain Management Revisited.
    Carr E
    Clin J Oncol Nurs; 2021 Aug; 25(4):361-362. PubMed ID: 34269344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID 19 on the provision of surgical services in Ontario, Canada: population-based analysis.
    Gomez D; Dossa F; Sue-Chue-Lam C; Wilton AS; de Mestral C; Urbach D; Baxter N
    Br J Surg; 2021 Jan; 108(1):e15-e17. PubMed ID: 33640924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use and misuse in Europe: COVID-19 new challenges?
    Torrens M; Fonseca F
    Eur Neuropsychopharmacol; 2022 Jan; 54():67-69. PubMed ID: 34565653
    [No Abstract]   [Full Text] [Related]  

  • 8. The escalation of the opioid epidemic due to COVID-19 and resulting lessons about treatment alternatives.
    Silva MJ; Kelly Z
    Am J Manag Care; 2020 Jul; 26(7):e202-e204. PubMed ID: 32672917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.
    Niles JK; Gudin J; Radcliff J; Kaufman HW
    Popul Health Manag; 2021 Feb; 24(S1):S43-S51. PubMed ID: 33031013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
    Oviedo-Joekes E; MacDonald S; Boissonneault C; Harper K
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):22. PubMed ID: 33673847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the Burden of Opioid-related Mortality in Ontario, Canada.
    Gomes T; Greaves S; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    J Addict Med; 2018; 12(5):418-419. PubMed ID: 29697503
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids in the United Kingdom: safety and surveillance during COVID-19.
    Osborne V
    Curr Opin Psychiatry; 2021 Jul; 34(4):357-362. PubMed ID: 33993168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update: COVID-19 Upends Progress on Opioid Crisis.
    Am J Nurs; 2020 Oct; 120(10):16. PubMed ID: 32976135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Opioid Epidemic in the Age of the COVID-19 Pandemic.
    Nair L; Duggan RP; Moliver CL
    Aesthet Surg J; 2022 Feb; 42(3):325-326. PubMed ID: 34653243
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioids and Acute Kidney Injury.
    Mallappallil M; Bajracharya S; Salifu M; Yap E
    Semin Nephrol; 2021 Jan; 41(1):11-18. PubMed ID: 33896468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Opioid Epidemic and the COVID-19 Pandemic: Similarities in Biology and Differences in Response to 2 Public Health Crises.
    Padala AP; Wilson KB; Das A
    Prim Care Companion CNS Disord; 2022 Jan; 24(1):. PubMed ID: 35052021
    [No Abstract]   [Full Text] [Related]  

  • 19. Perinatal Outcomes During the COVID-19 Pandemic in Ontario, Canada.
    Simpson AN; Snelgrove JW; Sutradhar R; Everett K; Liu N; Baxter NN
    JAMA Netw Open; 2021 May; 4(5):e2110104. PubMed ID: 33978727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
    Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH
    Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.